SOLICITATION NOTICE
U -- Clinical Biochemical Genetics and Clinical Genetics Training
- Notice Date
- 9/30/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 611699
— All Other Miscellaneous Schools and Instruction
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- NHLBI-PB-(HG)-2010-002-TMB
- Archive Date
- 10/20/2009
- Point of Contact
- Tracy Brooks, Phone: (301) 435-0369
- E-Mail Address
-
brookstr@nhlbi.nih.gov
(brookstr@nhlbi.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation number is NHLBI-PB-(HG)-2010-002-TMB and is issued as a Request for Quotation (RFQ). The solicitation/contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2005-36. The North American Industry Classification (NAICS) Code is 611699 and the business size standard is $7.0 Million. This acquisition is being conducted using Simplified Acquisition Procedures in accordance with FAR Part 13. It is the intent of the National Institutes of Health (NIH) National Heart, Lung and Blood Institute to procure the services for the National Human Genome Research Institute (NHGRI), Division of Intramural Research (DIR) from University of Maryland, 655 W. Baltimore Street, Room 11-037, Baltimore, MD 21201 for the following as outlined in the statement of work: Background: The National Human Genome Research Institute (NHGRI), Division of Intramural Research (DIR) was established to serve as a hub where development of technology for the rapid isolation and analysis of disease genes will be carried out. The DIR=s basic research laboratories and clinical branches develop and use the most advanced techniques to conduct research in medical genetics. Research includes identifying and understanding the molecular basis of human genetic disease and planning and carrying out clinical trials to test methods for the treatment. The mission of the DIR includes the training of physicians and doctoral degree fellows in medical genetics through the Metropolitan Washington D.C. Medical Genetics Residency Program. The Metropolitan Washington D.C. Medical Genetics Residency Program is administered by the Office of the Clinical Director (OCD) and is accredited by the American Board of Medical Genetics (ABMG). Requirements for board certification of competency of the trainees includes laboratory experiences in molecular genetics. To meet these requirements the Medical Genetics Branch and OCD seek nearby institutions to provide these components of training for board certification in Clinical Genetics, Ph.D. Medical Genetics, Clinical Molecular Genetics, Clinical Biochemical Genetics and Clinical Cytogenetics. This institution or group of institutions must also provide the opportunity for trainees in Clinical Genetics, Clinical Biochemical Genetics and Ph.D. Medical Genetics, to see patients with genetic disorders under the direction of an ABMG board certified geneticist. The laboratory experience of the trainees must include a wide array of molecular diagnostic testing in the fields of neurodegenerative disorders, late onset disorders, imprinting disorders, mental retardation, neuromuscular disorders, and metabolic diseases, including prenatal diagnosis. The laboratory aspect of the training program will need to be conducted in molecular diagnostic laboratories with equipment and personnel to provide the hands-on experience required for board certification by ABMB. The staff, which must include ABMG board certified laboratory directors, will be required to train fellows in applicable laboratory techniques and the clinical interpretation and implications of the test results. The staff must also participate in the comprehensive teaching of fellows; including participation in lecture series, journal clubs, and case conferences. The cost of disposable supplies used by trainees will be included in the contract. This project is required for NHGRI/DIR to help provide the DIR with access to CLIA/CAO and ABMG approved settings to train fellows in the laboratory techniques of molecular genetics for the diagnosis of genetic disorders and the genetic implications of these test results. The purpose of this contract is to maintain formal training program sites for the instruction of medical and doctoral fellows as part of the requirements for board certification in Clinical Genetics, Clinical Cytogenetics, Clinical Biochemical Genetics and Clinical Molecular Genetics. The goals of the program are to: 1.Provide a training facility that will conduct one-month training experience in molecular diagnostics for each of our Clinical Genetics, Clinical Cytogenetics, and Clinical Biochemical Genetics trainees. 2.Provide a training facility that will conduct up to six month training experiences in molecular diagnostics of genetic disorders for trainees seeking ABMG board certification in Molecular Genetics. 3.To participate in the comprehensive training of all trainees in genetics as part of the Metropolitan Washington D.C. Medical Genetics Residency Program. The contractor shall perform the specific tasks: 1. Each year the training program will enroll up to four (4) clinical genetics fellows, two (2) cytogenetics fellows, and two (2) biochemical fellows. Each of these fellows will spend one (1) month each in the molecular diagnostics laboratory for rare genetic diseases. 2. Each year the training program will enroll up to three (3) molecular genetics fellows. Each of these fellows will spend six (6) months in the molecular diagnostics laboratory. NHGRI mentors will determine sessions. 3. Track the progress of each fellow to insure that they will have had necessary experiences for AMGB certification. Quality Control The Contractor shall establish and adhere to time lines for: 1. Providing the fellow with up-to-date protocols at the start of the rotation, and providing protocol modifications that occur during the rotation. 2. Providing all the required experiences for board certification with each month period. 3. Follow the guidelines established by the American College of Medical Genetics for conducting genetic diagnostic tests. 4. Evaluating each medical fellow to insure they have a full understanding of all the techniques taught during training experiences. 5. Having sufficient samples submitted to the laboratory so that the fellows can have first-hand involvement in 150 cases of sufficient variety to qualify for ABMG Board eligibility. 6. Having the fellow participate in the interpretation of proficiency tests if such tests are conducted during the rotation period. 7. Personnel qualifications are to be provided by the Contractor to the Project Officer for review and approval prior to the award of the contract. Required Reports/Deliverables: The Contractor shall prepare and deliver quarterly progress reports in the quantities specified to the recipients designated: Description of Reports: Quarterly Progress Report B A Quarterly Progress Report shall be submitted to the Project Officer within 30 calendar days after each three (3) month reporting period. This report shall include the following information: 1.Number of fellows instructed in molecular genetics. 2.Number of fellows recommended repeating all or parts of the training sessions and why. 3.A narrative explaining any problems encountered that quarter, when they occurred and how they were resolved. The proposed period of performance for this service will consist of one (12) month base period (October 1, 2009 through September 30, 2010) and will include three (3) options to renew for a twelve month period per fiscal year. The sole source is based on the fact that University of Maryland, Biochemical Genetics Laboratories provides training in the laboratory diagnosis of rare molecular disorders. This training is a segment of the mandated curriculum of the Washington DC Metropolitan Genetics Fellowship Training Program required for Board certification in Clinical Genetics, Clinical Biochemical Genetics, Cytogenetics and /or Molecular Genetics. This training must be provided in CLIA approved, academic laboratories with expertise in this type of laboratory testing. Due to the fact that most of the tests are diagnostic for very rare disorders this is the only facility that meet the ABMG training criteria within a 40 mile radius of the National Institutes of Health facility to allow Fellows to maintain their responsibilities at the NIH Clinical Center and train in these settings. The evaluation will consist of the following criteria: (1) The Contractor shall describe procedures needed to successfully train the fellows in required laboratory techniques and the genetic implications of the molecular diagnostic tests. (2) The Contractor shall arrange to have suitable facilities, which include dedicated space for performance of administrative duties associated with tracking the progress of the medical fellows through the training. (3) Demonstrated knowledge and understanding of the statement of work. The offeror must include a completed copy of the following provisions: 1) FAR Clause 52.212-1 Instructions to Offerors Commercial; 2) FAR Clause 52.212-2, Evaluation Commercial Items. As stated in FAR Clause 52.212-2 (a), The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: Technical Evaluation and Price. 3) FAR Clause 52.212-3, Offeror Representations and Certifications Commercial Items; 4) FAR Clause 52.212-4, Contract Terms and Conditions Required To Implement Statues or Executive Orders Commercial Items, Contract Terms and Conditions Commercial Items; and 5) FAR Clause 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items Deviation for Simplified Acquisitions. This action is under the authority of 41 U.S.C. 253(c)(1), as set forth in FAR 6.302-1 and HHSAR 306-302-1. Only one responsible source and no other supplies or services will satisfy agency requirement. Interested parties may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations however; all responses received within 5 days from the date of publication of this synopsis will be considered by the Government. A determination by the Government not to compete this proposed acquisition is based upon responses to this notice and is solely for the purpose of determining whether to conduct a competitive acquisition. The offeror must include in their quotation, the unit price, the list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. Note: In order to receive an award from the NHLBI contractors must have a valid registration in the Central Contractor Registration (CCR) www.ccr.gov. The clauses are available in full text at http://www.arnet.gov/far. Interested vendors capable of furnishing the government with the item specified in this synopsis should submit their quotation to the below address. Quotations will be due five (5) calendar days from the publication date of this synopsis or by October 5, 2009, 7:30am, Eastern Standard Time. The quotation must reference Solicitation number NHLBI-PB-(HG)-2010-002-TMB. All responsible sources may submit a quotation, which if timely received, shall be considered by the agency. Quotations must be submitted in writing to the National Heart, Lung and Blood Institute 6701 Rockledge Blvd., Room Suite 6149, Bethesda, Maryland 20892, Attention: Tracy Brooks. Responses may be submitted electronically to brookstr@nhlbi.nih.gov. Responses will only be accepted if dated and signed by an authorized company representative.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/NHLBI-PB-(HG)-2010-002-TMB/listing.html)
- Place of Performance
- Address: NIH, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN01976574-W 20091002/091001001945-27f4a5fe9791dc7c679355e3d26d2747 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |